
Fighting Familial Juvenile Hyperuricemic Nephropathy Type 2: The Promise of Genetic Testing
Uric acid builds up in the blood when the kidneys cannot excrete it properly, leading to gout, kidney stones and, over time, chronic kidney disease.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

Uric acid builds up in the blood when the kidneys cannot excrete it properly, leading to gout, kidney stones and, over time, chronic kidney disease.

RAD51C, a gene used in homologous recombination repair, is altered in group O, which presents with hematologic abnormalities, developmental delays and cancer risk.

A recurrent HNF4A variant disturbs how the kidneys reabsorb nutrients and electrolytes, and the reported clinical spectrum now takes in congenital anomalies.

The P209L variant in the TRPC6 gene has been tied to adult-onset FSGS5; identifying it supports earlier monitoring, treatment choices and genetic counseling.

Underdeveloped eyes and profound facial clefts mark this frontonasal dysplasia syndrome, and studies of the ALX1 gene show how genetic testing can confirm it.

Loss of the enzyme that breaks down GABA lets it build up in the brain, causing the seizures, hypotonia and developmental delay of GABA-T deficiency.

Vision can be lost before any symptom appears, so genetic markers are used to stratify risk, set monitoring intervals and match patients to likely treatments.

Eye pressure rises at birth or in early childhood, and variants in CYP1B1, TEK, ZC2HC1C, VPS13D and PGF can confirm the diagnosis and inform family planning.